Telehealth weight loss looks simple from the outside: answer some questions, get a box in the mail. Under the hood there are five separate hand-offs — an intake quiz, a clinician review, a prescription, a pharmacy fill, and a shipment — and each one has rules that separate a legitimate medical program from an illegal storefront. This guide walks the whole pipeline in order, explains who is actually prescribing and where the medication really comes from, and ends with a checklist to run before you give any website your card number.
The Telehealth Weight Loss Pipeline at a Glance
Every major platform follows the same basic sequence. The brand names change; the plumbing does not.
| Step | What happens | Typical time |
|---|---|---|
| 1. Intake quiz | You answer health, weight, and medication questions online | 10–20 minutes |
| 2. Clinician review | A state-licensed clinician reviews your answers, async or by video | 24–72 hours at many providers |
| 3. Prescription | If you qualify, the clinician sends a prescription to a partner pharmacy | Same day as approval |
| 4. Pharmacy fill and shipping | A brand-name or compounding pharmacy fills and ships the order | Roughly 2–7 days |
| 5. Refills | Brief check-ins on side effects and progress before each shipment | Monthly or quarterly |
Two structural facts frame everything below. First, the platform you pay is usually not a medical practice — it connects you to independent clinicians who make the actual prescribing decisions. Second, the pharmacy that fills the order matters as much as the website that took your money.
Step 1: The Intake Questionnaire
The process starts with an online health questionnaire that takes about 10 to 20 minutes. Expect questions about your height and weight, weight history, current medications, digestive and thyroid history, mental health, and pregnancy status or plans. Most platforms also verify your identity with a photo ID, and some ask for a recent weight photo or basic labs.
The clinical bar comes from the FDA-approved drug labels, and NIDDK summarizes it the same way: prescription weight management drugs are generally for adults with a BMI of 30 or higher, or 27+ with at least one weight-related condition such as high blood pressure, type 2 diabetes, or sleep apnea. Certain answers should stop the process cold — a personal or family history of medullary thyroid carcinoma or MEN 2 syndrome, a history of pancreatitis, current pregnancy, or an active eating disorder are standard disqualifiers.
Answer honestly. An asynchronous clinician can only act on what you type, and misstating your BMI or history removes the only safety screen standing between you and a prescription drug.
Step 2: Clinician Review — Async or Video?
In most states, a licensed clinician may review your questionnaire asynchronously — in writing, with no appointment — and prescribe if you qualify. You may get follow-up questions by secure message, then a decision. The providers we track commonly advertise decisions within 24 to 72 hours of a completed intake.
A handful of states instead require a live video or phone visit before a new prescription can be written. A legitimate platform detects your state from your address and books the call automatically, so you do not need to memorize telehealth law. Either way, one rule never changes: the clinician must hold a license in the state where you live, not just the state where the company is headquartered.
Who Actually Prescribes? Independent Clinician Networks
Most telehealth platforms are technology and marketing companies, not medical practices. The medicine happens inside independent clinician networks — groups of licensed physicians, nurse practitioners, and physician assistants that the platform contracts with. MEDVi, for example, routes its visits through OpenLoop Health’s clinician network.
This split matters for two reasons. Because the prescribing decision legally belongs to the clinician, a real program can and does reject applicants — several major providers state plainly that a prescription is never guaranteed, and that is a good sign, not a bad one. And you should always be able to see your prescriber’s name, message them with questions, and verify their license on your state medical board’s website in about two minutes.
Step 3: Pharmacy Fulfillment — 503A vs 503B
Approved prescriptions travel one of two roads. The brand-name road ends at a dispensing pharmacy or manufacturer channel shipping FDA-approved Wegovy or Zepbound — at retail cash prices around $1,300+ per month without insurance, or $199–$399 monthly through some telehealth cash programs. The compounded road ends at a compounding pharmacy making semaglutide or tirzepatide for roughly $99 to $449 per month, per the July 2026 pricing we track.
Compounding pharmacies come in two legal classes under the FDA’s compounding framework:
| 503A pharmacy | 503B outsourcing facility | |
|---|---|---|
| Fills | Patient-specific prescriptions, one at a time | Large batches |
| Primary oversight | State boards of pharmacy | Registers with the FDA; subject to FDA inspection |
| Manufacturing standard | Traditional pharmacy compounding standards | Federal CGMP — closer to drug-manufacturer rules |
Neither class makes the drug approved: compounded semaglutide and tirzepatide are not FDA-approved, and the FDA has received reports of dosing errors and adverse events with compounded GLP-1s — including patients who drew 5 to 20 times the intended dose from multi-use vials. Before choosing the compounded road, read our compounded semaglutide safety guide, and favor providers that name their exact pharmacies and their 503A or 503B status.
Step 4: Shipping, Refills, and Dose Changes
Medication arrives in roughly 2–7 days after approval, usually in a cold pack — with syringes, alcohol pads, and draw instructions if it is a compounded vial. Refrigerate it on arrival and follow the storage sheet exactly. Semaglutide is a temperature-sensitive medication, not a shelf-stable pill.
Refills run on check-ins. Expect a short questionnaire about side effects and progress before each shipment, because your dose is designed to climb: the Wegovy prescribing information steps semaglutide from 0.25 mg to 2.4 mg weekly over about 16 weeks. Watch the billing mechanics here — some programs raise the price as your dose rises, some bill quarterly lump sums, and membership fees of up to $149 per month can sit on top of medication. Our GLP-1 cost breakdown maps the full first-year math, and because nearly all of these programs are cash-pay by design, our roundup of GLP-1 without insurance options shows what each path costs without coverage.
Set expectations on trial timelines, not marketing timelines. In the STEP 1 trial, weekly 2.4 mg semaglutide plus diet and exercise produced about 14.9% average weight loss over 68 weeks; in SURMOUNT-1, tirzepatide’s highest dose produced up to 20.9% over 72 weeks. Individual results vary widely, and no program can promise yours.
The Telehealth Weight Loss Legitimacy Checklist
Run any telehealth weight loss site through six checks before paying:
- A prescription is required. Semaglutide and tirzepatide are prescription-only drugs. No questionnaire, no clinician, no sale.
- Licensed clinicians you can identify. You should learn your prescriber’s name and be able to verify the license with your state medical board.
- Named pharmacies. The best disclosures name the exact compounding pharmacy and its 503A or 503B status — not just a vague ‘US-licensed pharmacy’ claim.
- A real company behind the site. Look for a physical US address, a legal entity name, and working phone, email, or chat support.
- Plain pricing. First-month price, ongoing price, membership fees, and dose-increase pricing should all be visible before checkout.
- Honest labeling. Compounded medication described as compounded and not FDA-approved — never the reverse.
Our comparison of the best weight loss injections applies these same checks, with verified prices, across 10 major providers.
Red Flags: When to Close the Tab
Some failures are disqualifying on their own. A site that sells GLP-1s without any prescription is breaking the law and telling you exactly how much it cares about your safety — the FDA has warned specifically about unapproved GLP-1 products sold outside legitimate channels. ‘Guaranteed approval’ is the same tell in different clothing: a medical review that approves everyone is not a medical review.
Watch also for compounded drugs marketed as ‘FDA-approved’ — the FDA has sent warning letters to telehealth sellers for exactly that claim — plus prices hidden behind signup walls, no physical address, no named pharmacy, and before-and-after ads promising specific results on a schedule. The medications are real and the trial data is strong. But in this market, the difference between a clinic and a storefront is the paperwork, and legitimate programs are happy to show theirs.